Elite Pharmaceuticals, Inc. Interest Payable, Current
Elite Pharmaceuticals, Inc. (ELTP) had Interest Payable, Current of $104.39 thousand as of 2022-12-31, per its 10-Q filed 2023-02-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2023-02-14
- 2022-12-31: Interest Payable, Current $104.39K.
- 2022-09-30: Interest Payable, Current $85.14K.
- 2022-06-30: Interest Payable, Current $61.30K.
- 2022-03-31: Interest Payable, Current $7.37K.
| Period end | Interest Payable, Current | Interest Payable, Current as first filed |
|---|---|---|
| 2022-12-31 | $104.39K 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $85.14K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $61.30K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $7.37K 10-K · filed 2022-06-29 | |
| 2021-12-31 | $29.47K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $7.37K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $31.85K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $7.96K 10-K · filed 2022-06-29 | |
| 2020-03-31 | $7.96K 10-Q · filed 2021-11-15 | $8.53K 10-K · filed 2021-06-14 |